Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Adachi Y, Kamiyama H, Ichikawa K, Fukushima S, et al. Inhibition of FGFR Reactivates IFNgamma Signaling in Tumor Cells to Enhance the Combined Antitumor Activity of Lenvatinib with Anti-PD-1 Antibodies. Cancer Res 2022;82:292-306.
PMID: 34753772


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016